Related Experiment Video
Updated: Jun 30, 2025

09:20
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
8.5K
HDAC7: a promising target in cancer
Cui Liu1, Dan Zheng1, Xuan Pu1
1Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Frontiers in Oncology
|March 15, 2024
Summary
Histone deacetylase 7 (HDAC7) plays a key role in tumor development and drug resistance. Targeting HDAC7 offers a promising strategy for cancer treatment and improving patient prognosis.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- Histones are crucial for chromatin structure and gene regulation.
- Histone deacetylases (HDACs) compact chromatin, suppressing gene transcription.
- HDAC7, an HDAC family member, is implicated in various pathophysiological processes.
Purpose of the Study:
- To review the structure, function, and role of HDAC7 in tumor development.
- To explore HDAC7's involvement in tumor growth, metastasis, and drug resistance.
- To discuss HDAC7's interplay with signaling pathways and its therapeutic potential.
Main Methods:
- Literature review of studies on HDAC7 in cancer.
- Analysis of HDAC7's structural and functional characteristics.
- Examination of HDAC7's role in tumor pathogenesis and signaling pathways.
Main Results:
- HDAC7 significantly influences tumor growth, metastasis, and angiogenesis.
- HDAC7 contributes to the development of drug resistance in various cancers.
- HDAC7's deacetylation activity impacts cellular processes relevant to cancer progression.
Conclusions:
- HDAC7 is a critical factor in tumor pathogenesis and progression.
- HDAC7 holds potential as a prognostic biomarker for cancer patients.
- Targeting HDAC7 presents a promising therapeutic strategy for overcoming drug resistance in cancer.
Related Concept Videos
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

